Trials / Unknown
UnknownNCT06163911
In-depth ECG Analysis for the Extraction of Biomarkers of Cardiac Mechanical Dispersion
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- —
Summary
Left ventricular systolic dysfunction (LVSD) refers to impaired contraction of the left ventricle, and can lead to heart failure and death. Early identification of LVSD, which often remains asymptomatic for years, is therefore crucial to mitigate the associated risks through appropriate treatment. Echocardiographic screening of asymptomatic individuals is costly, requires access to experts, and the criteria for selecting potential high-risk individuals for screening remain unclear. Unlike echocardiography, the electrocardiogram (ECG) is a relatively low-cost procedure, routinely available and requiring little technical training to set up the examination and collect data, making it an interesting tool for early detection of LVSD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ECG | Routine care 12-lead electrocardiogram |
| DEVICE | Echocardiography | Routine care echocardiography |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2024-11-30
- Completion
- 2025-06-01
- First posted
- 2023-12-11
- Last updated
- 2023-12-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06163911. Inclusion in this directory is not an endorsement.